Reverb Therapeutics
Developer of a cytokine therapy designed for cancer treatment and promoting targeted immune activation while limiting toxicity. The company uses bispecific antibodies to localize endogenous cytokines ...
Valuation
$0
Share Price
N/A
Total Raised
$12.5M
Last Round
N/A